Company Filing History:
Years Active: 1979
Title: The Innovations of Jean-Louis Amiot
Introduction
Jean-Louis Amiot is a notable inventor based in Maromme, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of heparin salts. His work has implications for medical treatments, especially in anticoagulation therapies.
Latest Patents
Jean-Louis Amiot holds a patent for a process of preparing mixed heparin salts. This patent describes a mixed or simple heparin salt that has a reduced amount of a selected metal ion, either alone or in combination with another metal ion. The heparin salt is characterized by a reduced sodium content, being essentially sodium-free, while having a selectively high calcium or other selected salt content. The process for creating these heparin salts involves a reaction with the selected metal salt, which may include dialysis or precipitation. A typical example of this heparin salt is calcium heparin, which is essentially free of sodium, containing less than about 1% by weight of sodium. Additionally, mixed calcium-sodium heparin can be produced with a limited, predetermined sodium content. The drug compositions that utilize these heparin salts, along with a pharmaceutical carrier, are particularly useful as anticoagulants.
Career Highlights
Jean-Louis Amiot has worked with Choay, S.A., where he has been able to apply his innovative ideas in the pharmaceutical industry. His work has contributed to advancements in drug formulations that enhance patient care and treatment outcomes.
Collaborations
Throughout his career, Jean-Louis Amiot has collaborated with notable individuals such as Jean Choay and Jean Goulay. These collaborations have likely fostered an environment of innovation and shared expertise in the field of pharmaceuticals.
Conclusion
Jean-Louis Amiot's contributions to the development of heparin salts represent a significant advancement in medical science. His innovative processes and collaborations have paved the way for improved anticoagulant therapies, benefiting patients worldwide.